Global Genomics Personalized Health Market Size study, by Technology (NGS Platform, RT-PCR, Microarray, Genetic Analyzer, Others), by Test Type (Oncology Testing, Infectious Disease Testing, Orphan Disease Testing, Autoimmune Disease Testing, Obstetrics T

Global Genomics Personalized Health Market Size study, by Technology (NGS Platform, RT-PCR, Microarray, Genetic Analyzer, Others), by Test Type (Oncology Testing, Infectious Disease Testing, Orphan Disease Testing, Autoimmune Disease Testing, Obstetrics Testing, Others), by End User (Academics & Research Institutes, Diagnostic Centers, Others) and Regional Forecasts 2022-2032

Global Genomics Personalized Health Market is valued approximately at USD 9.17 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 12.23% over the forecast period 2024-2032. Genomic personalized health represents a transformative approach to medical treatment, utilizing genetic information to tailor therapies and interventions to individual patients. This sophisticated methodology enables the identification of complex conditions and facilitates the development of specialized treatments and therapies based on genetic profiling. By integrating genomic data into healthcare, traditional medications that may be ineffective or have adverse effects on specific patient groups can be avoided, thereby enhancing treatment efficacy and patient safety.

The Global Genomics Personalized Health Market is driven by increasing demand for early diagnosis and the surge in investments in research and development activities. The early diagnosis of diseases through genetic profiling allows for timely and more effective intervention, significantly improving patient outcomes. Moreover, substantial investments in R&D are fostering innovations in genomics technologies, which are essential for the advancement of personalized health solutions. In addition, increasing focus on personalized medicine, coupled with the rapid advancements in genomic technologies, positions the genomics personalized health market for substantial growth. As healthcare providers and institutions continue to adopt these advanced systems, the market is expected to expand significantly, offering improved healthcare outcomes through tailored medical interventions. However, lack of skilled professionals is going to impede the overall demand for the market during the forecast period 2024-2032.

The key regions considered for the Global Genomics Personalized Health Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America dominated the market driven by elevated healthcare expenditure, heightened awareness, and the growing demand for personalized medicine. The region's robust market dynamics are further propelled by advancements in genomics technologies, the presence of major pharmaceutical companies and research organizations, and the high prevalence of chronic diseases. These factors collectively strengthen North America's leading position in the genomics personalized health market. Furthermore, the market in Asia Pacific is anticipated to develop at the fastest rate over the forecast period 2024-2032.

Major market players included in this report are:

QIAGEN

Illumina, Inc.

Thermo Fisher Scientific, Inc.

Bio-Rad Laboratories, Inc.

Hoffmann-La Roche AG

Lonza Group

Invitae Corp

Genetic Technologies Limited

Interleukin Genetics Inc.

Eastern Biotech and Life Sciences

DNA Genotek Inc.

uBiome, Inc.

XCode Life Sciences Private Limited

The detailed segments and sub-segment of the market are explained below:

By Technology
• NGS Platform
• RT-PCR
• Microarray
• Genetic Analyzer
• Others

By Test Type
• Oncology Testing
• Infectious Disease Testing
• Orphan Disease Testing
• Autoimmune Disease Testing
• Obstetrics Testing
• Others

By End User
• Academics & Research Institutes
• Diagnostic Centers
• Others

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC

Latin America
• Brazil
• Mexico
• RoLA

Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA

Years considered for the study are as follows:
• Historical year – 2022
• Base year – 2023
• Forecast period – 2024 to 2032

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.